Perrigo | PRGO - Current Assets



Perrigo reported $2.62B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
AbbVie USD 27.68B 2.09B Mar/2025
Abbott USD 24.47B 1.32B Jun/2025
Bayer EUR 33.75B 1.08B Jun/2025
Bristol-Myers Squibb USD 33.22B 2.44B Jun/2025
Corcept Therapeutics USD 443.11M 4.61M Jun/2025
Dr.Reddys Laboratories INR 269.9B 19.72B Jun/2025
Eli Lilly USD 49.85B 8.59B Jun/2025
J&J USD 71.55B 15.66B Mar/2025
Merck USD 37.07B 1.56B Jun/2025
Nestle CHF 33.43B 1.76B Jun/2025
Pacira USD 745.61M 14.35M Jun/2025
Perrigo USD 2.62B 82M Jun/2025
Pfizer USD 43.7B 2.16B Jun/2025
Prestige Brands USD 480.52M 32.19M Jun/2025
Reckitt Benckiser GBP 4.6B 287M Dec/2024
Sanofi 37.02B 7B Jun/2025
Supernus Pharmaceuticals USD 738.87M 51.28M Jun/2025
Teva Pharmaceutical Industries USD 12.62B 1.09B Jun/2025
Xeris Pharmaceuticals USD 185.58M 17.92M Jun/2025
Zoetis USD 5.92B 46M Jun/2025